Discover 1,243 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,243
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
for
Smoldering Plasma Cell Myeloma
Location: Nashville TN, Louisville KY, Carterville IL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT03937635
Phase 3, Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
for
Pancreatic Neoplasm
Location: Nashville TN, Knoxville TN, Carterville IL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 50 - 70+
Code: NCT04239573
Recruiting
Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
for
HER2-Positive Solid Tumor
Location: Nashville TN
Sponsor: Yuhan Corporation
Sex: All
Age: 18+
Code: NCT05523947
Phase 1, Phase 2, Recruiting
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Nashville TN, Atlanta GA, Chicago IL, Durham NC,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07621718
Phase 3, Recruiting
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Location: Nashville TN, Lexington KY, Atlanta GA, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07003295
Phase 2, Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Nashville TN, Atlanta GA, Effingham IL, Shiloh IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07195734
Phase 2, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Nashville TN, Carterville IL, Carbondale IL,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07097142
Phase 3, Recruiting
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
for
Advanced Renal Cell Carcinoma (aRCC),
Location: Nashville TN, Chapel Hill NC, Milwaukee WI,
Sponsor: Brian Rini
Sex: All
Age: 18+
Code: NCT07188896
Phase 2, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Location: Nashville TN, Evansville IN, Louisville KY,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: Nashville TN, Lexington KY, Atlanta GA, Shiloh IL,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase 2, Phase 3, Recruiting
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Nashville TN, Louisville KY, Knoxville TN, Atlanta GA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06769698
Phase 2, Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
for
Breast Cancer (Triple Negative Breast Cancer (TNBC)),
Location: Nashville TN
Sponsor: Jessica Mezzanotte Sharpe
Sex: All
Age: 18+
Code: NCT07555210
Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease